Skip to main content

Table 6 Cumulative hospitalization at one and three months and changes in vital signs from baseline to three and twelve months after surgery

From: Autologous umbilical cord blood mononuclear cell therapy for hypoplastic left heart syndrome: a nonrandomized control trial of the efficacy and safety of intramyocardial injections

 

Treatment group

(n = 50)

Control group

(n = 45)

P value

Change in vital signs (weight, heart rate, O2 saturation)

Change in weight at

3 months (n)

44

39

0.956*

Median (Q1, Q3)

1.2 (0.9, 1.5)

1.2 (0.7, 1.8)

 

Change in weight at

12 months (n)

40

36

0.277*

Median (Q1, Q3)

3.5 (2.9, 4.3)

3.5 (2.3, 4.2)

 

Change in heart rate at

3 months (n)

43

38

0.909*

Median (Q1, Q3)

5.0 (-8.0, 14.0)

3.0 (-9.0, 17.0)

 

Change in heart rate at

12 months (n)

37

34

0.259*

Median (Q1, Q3)

-10.0 (-13.0, 8.0)

1.0 (-12.0, 14.0)

 

Change in O2 saturation at

3 months (n)

40

36

0.639*

Median (Q1, Q3)

4.0 (1.0, 8.5)

5.5 (0.5, 9.5)

 

Change in O2 saturation at

12 months (n)

38

29

0.301*

Median (Q1, Q3)

4.0 (0.0. 9.0)

2.0 (-3.0, 8.0)

 

Cumulative Hospitalization

At 1 month, days

  

0.776*

Median (Q1, Q3)

8.5 (6.0, 22.0)

10.0 (6.0, 16.0)

 

At 3 months, days

  

0.878*

Median (Q1, Q3)

8.5 (6.0, 22.0)

10.0 (6.0, 16.0)

 

*Kruskal‒Wallis.

  Â